Hanmi Pharmaceutical Group Faces Renewed Governance Turmoil as Shareholder Alliance Fractures

Reporter Kim Jisun / approved : 2025-08-18 03:47:44
  • -
  • +
  • 인쇄

Photo courtesy of Yonhap News

 

 

[Alpha Biz= Kim Jisun] Hanmi Pharmaceutical Group has plunged into a new round of internal conflict over management control, less than a year after a truce was reached between rival family factions. This time, the discord has emerged within the controlling shareholder alliance itself, raising concerns that prolonged disputes could damage corporate value and create a leadership vacuum.



According to investment banking sources, Chairwoman Song Young-sook, her eldest daughter and Vice Chairwoman Lim Ju-hyun, and La Défense Partners’ special purpose company (SPC) Killington LLC have moved to seize shares and assets belonging to Shin Dong-guk, chairman of Hanyang Precision and the largest individual shareholder of Hanmi Science. They secured a court injunction to provisionally seize Shin’s Hanmi Science shares valued at approximately ₩12 billion, as well as his Hannam The Hill apartment in Seoul, worth about ₩10 billion.



Until recently, Shin had been aligned with Song and Lim, forming a “four-party alliance” (Song, Lim, Shin, and La Défense Partners) to counterbalance the late founder’s sons, Lim Jong-yoon and Lim Jong-hoon. The alliance successfully secured majority control of Hanmi Science, the group’s holding company. However, tensions flared after Shin allegedly breached the alliance agreement, which granted members preemptive rights to buy each other’s shares, by seeking to sell his stake externally.



The conflict intensified following Shin’s issuance of three exchangeable bonds (EBs) on July 29 under Hanyang Precision, raising ₩38.45 billion. The bonds were exchangeable for stakes in Hanmi Pharmaceutical (₩19.75 billion), Dong-A ST (₩3.72 billion), and Dong-A Socio Holdings (₩14.99 billion). Earlier in January, Shin had carried out a similar transaction, securing around ₩50 billion through EB issuances tied to the same companies.



Meanwhile, Song and Lim have been pursuing a strategic partnership with OCI Group to secure shares and address a looming inheritance tax bill of about ₩540 billion. Shin, a long-time acquaintance of Hanmi’s founder, initially appeared to back the brothers but later joined forces with Song and Lim—until the recent rupture.



Industry observers warn that if the infighting persists, it could undermine investor confidence and disrupt the group’s succession and long-term strategy.

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Shinhan Investment Raises LG Innotek Target Price to ₩280,000 on Earnings Recovery and 2025 Growth Outlook2025.10.31
Woori Bank Sanctioned by Financial Supervisory Service for Delayed Reporting of Overseas Regulatory Actions2025.10.31
Samyang Foods Raises U.S. Supply Prices for Buldak Ramen Amid Tariff Impact2025.10.31
NH Investment & Securities Suspends IB Executive Under Investigation for Alleged Insider Trading2025.10.31
Heungkuk Life to Secure KRW 840 Billion in Liquidity Through Headquarters Sale and Bond Issuance — Preparing for AIGIS Asset Management Acquisition Bid2025.10.31
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사